¡°	alendronate monosodium trihydrate	8.783723676088089
	alendronic acid basis	5.454868491450737
	alendronic acid active basis	4.3799608600194695
	alendronic acid weight basis	4.365864303730705
	alendronate derivative	3.691331070031722
	alendronic acid active weight basis	3.651608642157987
	alendronate core molecule	3.6301412313660872
	even oral alendronate	3.6012791884252437
	Fosamax	3.42174968235027
	weekly treatment	2.9709771250679555
	active alendronate compound	2.7346564488111813
	two Lunar News article	2.7204298357762853
	alendronate acid active basis	2.2294263559066425
	alendronate pharmaceutically acceptable salt	2.1995055247431745
	weekly oral dosage	2.1286594464792388
	bisphosphonate compound	2.1119218849836696
¡°	oral bisphosphonate	2.084692043889878
	weekly dosing	1.8040718253296617
	bone resorption inhibit bisphosphonate	1.451450006927562
	osteoporosis prevention	1.1373050734535266
	GI complication	1.0989604829712367
	osteoporosis drug	1.0861156470199165
	weekly dosage amount	1.0669174914128667
	weekly dose overcame concern	0.8509601395508652
	adverse GI problem	0.6745175280339359
	seven daily mg dos	0.5788941975346831
	Bisphosphonate	0.571959787347482
	rigorous dosing instruction	0.5441289861414723
	standard osteoporosis treatment	0.5405427490796771
	adverse GI side effect	0.5065697792615563
	rigorous dosing regiman	0.4967078152111152
	zolendronate	0.49592674788727426
	article.5	0.49592674788727426
	Alendronate	0.49592674788727426
	costs.6	0.49592674788727426
	DeGroen	0.49592674788727426
	physician	0.49256839217480886
	dosing interval	0.4692013058889126
	repetitive irritation	0.44982722878787906
	high oral dosing	0.42450999285929747
	proposition	0.4086774862278561
	interest	0.4085280222110115
	Update	0.3987083840290196
	Inhibiting Bone Resorption	0.39356626413536516
	Brookhill Wilk	0.38130652489832134
	patient esophagus	0.37143215434590476
	Paget disease	0.36882597670260947
	bone disease	0.366204780873804
	deliberateness	0.36029001050221166
	gastrointestinal GI tract	0.3547968376661177
	seven daily dos	0.343166052529902
	mixed nomenclature	0.3285228940854768
	small daily dos	0.32834276962924
	risedronate	0.2860636604898017
	breakfast	0.2860636604898017
	bone destruction process	0.2666311451730764
	approximately".7	0.24796337394363713
	relatively diminish daily dose	0.23789786431108567
	seven time daily dose	0.23536096647699897
	high dosage	0.22450198440021327
	upper gastrointestinal distress	0.2243597331241387
	ibandronate	0.19941258516138066
	juice	0.19941258516138066
	Transp	0.19941258516138066
	daily formulation	0.19459169572574442
	oral dose	0.19231028649386195
	peer review journal	0.18004803680562004
	esophageal injury	0.16794211997060082
	Paulsen	0.1655004511662265
	common denominator	0.16541627575677173
	reduce frequency dose schedule	0.1628833211514781
	acceptable dosage amount	0.15826155345045792
	dosage strength	0.15214381634129273
	ingestion	0.1511177682798779
	know dose relate gastrointestinal side effect	0.1441837768560451
	even coffee	0.14303272350139465
	patentee lexicography	0.1429533670044687
	lexicographer	0.14126038823220258
	normal unit dosage	0.12636974416067012
	precision	0.1257676244548154
	oral unit dosage	0.12383949053103079
	O.U.R. Sci	0.12067984172218645
	potassium	0.12016701870954292
	Medicine	0.12016701870954292
	Elekta Instrument S.A.	0.11985795907856273
	underlined sentence	0.11766455199637565
	excess verbiage	0.11494732485853085
	less daily administration	0.11277913775869301
	Golden Blount	0.11261115400434196
	derivative compound	0.11224871688276454
	accepted ordinary meaning	0.099784209054975
	regime	0.09970636525354816
	irritate effect	0.09556002763008414
	different derivative	0.09208199896414165
	Cryo Trans Inc.	0.08124613583986892
	Intuitive Surgical Inc.	0.07726838886304906
	counterintuitive definition	0.07464578669812126
	Azioni	0.07069704082985749
	author	0.05884765620578788
	allegation	0.05459999243844029
	Covad Communications Group	0.05132496505539172
	New England Journal	0.05087301238560716
	percentage	0.05035440101804783
	patient compliance	0.04970963382487299
	Telegenix Inc.	0.049314533927774386
	precede sentence	0.048822448552947796
	ANDA filing	0.048778189034053225
	active compound	0.04695151168204162
	Union Carbide Chems	0.04647627685197812
	empty stomach	0.04538201638552708
	one week	0.04439333488592997
	generic treatment	0.044285294767818464
	Network Servs	0.04144230715629563
	highlight sentence	0.040654922014119396
	great leap	0.040240377986056244
	thirty minute	0.03881010210815389
	Philip Morris Inc.	0.038221746345714826
	reasonable clarity	0.03806489637965778
	sufficient clarity	0.038049290813231475
	doctor concern	0.03587066448962333
	continuous schedule	0.03532468346627902
	oft repeat phrase	0.03517159318879494
	fast state	0.03371750249682581
	chemical compound	0.03153029848583119
	DISCUSSION	0.03048206455568103
	Richardson Vicks	0.030337343824808256
	Abbreviated New Drug Application	0.030231320724486848
	whatever quantity	0.028935516162670333
	active component	0.026864625939739692
	intermittent treatment program	0.026203962374927833
	Delaware	0.024271193779312333
	FDA approval	0.023862178317634736
	molecular weight	0.021116535455083643
	Gajarsa	0.02108543736183308
	Vitronics Corp.	0.019650310321599227
	phrase ambiguity	0.01943905803309816
	medication	0.016868602869909113
	Review	0.01618553308270143
	herein	0.01618553308270143
	exactly number	0.014238503542999634
	low oral bioavailability	0.01352287609286304
	approximately amount	0.012735785122600873
	Tex	0.012187573482733768
	exist ANDA	0.011557016195988689
	follow passage	0.011129501397271346
	B. Litigation	0.010757906003538625
	Hatch Waxman Act	0.010608982902659268
	Jr.	0.010581865070456824
	normal definition	0.009568339712092633
	July	0.008775941457621502
	Conceptronic Inc.	0.008736027705445555
	modify phrase	0.008370807106885479
	Digital Sys	0.008355311073165585
	heavy metal	0.00792535910904096
	human comprising	0.006798235766187494
	reversible error	0.006582029653183075
	i. BACKGROUND	0.006430221123274498
	objective indicia	0.0063129273746296375
	variation	0.006290892362060384
	Food Drug Administration	0.005750478312501835
	trade name	0.005705715015154899
	b difficulty	0.005676459731399704
	intrinsic evidence	0.005569051419132764
	B. Claim Construction	0.005543696038092659
	opening	0.004949195076648079
	notice	0.00456100952587794
	definite firm conviction	0.004560822620778326
	water	0.004406470984320701
	limit definition	0.004174616638405341
	something	0.0041613021928466045
	nonobviousness	0.0038825571493837792
	market generic version	0.003878831257588028
	A. Standard	0.0034598944484115785
	final judgment Order	0.0033367668938784015
	specific weight	0.0033347230424177927
	ordinary customary meaning	0.003220435454198196
	April	0.003220030423202081
	end wall	0.003003636548525309
	novel meaning	0.002927211036448414
	propose manufacturer	0.002221513820237934
	underlying factual finding	0.002091384231931493
	underlying factual determination	0.002089363075091162
	USA Inc.	0.002049749479097702
	FAS Techs	0.001954941591631469
	final Judgment order	0.0019384635382008887
	co inventor	0.0019032940894547809
	central issue	0.0018574269623073212
	small group	0.0018001847571824802
	express intent	0.0014678040594460534
	understanding	0.0014424378880878175
	content	0.0013840722003661278
	Obviousness	0.001362078284534635
	b size	0.0013278208741077254
	certain amount	0.0012529723735194098
	entire evidence	0.0011764947667211477
	August	0.0010592738630384247
	bench trial	0.0010141217917615727
	c high cost	0.0009689677151622383
	different meaning	0.0009623728652735484
	clear enough term	0.0009035698255128706
	context	0.000828434143958482
	effective date	0.000754728102601937
	R.Civ	0.0007479178159061216
	anticipation	0.0007479178159061216
	prior art publication	0.0007214301600261788
	presumption	0.0005504067924852141
	owner	0.0005269327049628027
	term ordinary meaning	0.0005169620109277874
	primary concern	0.00044353483303785244
	dependent limitation	0.0003764366634467115
	a.	0.0003558607791306237
	II	0.0003220793830409631
	course	0.00020455916523951463
	correct construction	0.0001766573346184592
	ultimate issue	0.00017636578707394586
	obviousness ruling de novo	0.00016377320689644448
	obviousness turn	0.0001302047577092404
	independent form	0.00012877851090339952
	end result	0.00012504858204535478
	law de novo	0.00011626041968206571
	specific example	0.00011498937375189885
	factual basis	0.00011333729384873113
	court review construction	0.00010944516027385836
	district court construction	0.00010943866073610993
	banc	0.00010677733374217879
	ordinary skill	0.00010655264578787983
	specification	0.00010643504385180438
	method	0.0001060627280059684
	write description	9.869001672425048e-05
	difference	8.789454288010694e-05
	second reasonable interpretation	8.700087818957146e-05
	underlie factual determination	8.538599966630584e-05
	another point	8.402962961194636e-05
	addition	7.808950666198997e-05
	emphasis	7.34852383239821e-05
	favor	6.74828362103367e-05
	two example	6.282303564168885e-05
	two type	5.046110468837239e-05
	invention date	4.989511993434571e-05
	four factual determination	4.89178495451425e-05
	background	4.758359762888465e-05
	particular term	3.79743026833218e-05
	district court obviousness analysis	3.4034789352362634e-05
	clear error	2.864674685569272e-05
	holding	2.4456273580706772e-05
	suit	2.038591735882816e-05
	jurisdiction	2.0180299481674794e-05
	district court opinion	7.812790555397555e-06
	trial court finding	6.793773186768112e-06
	support evidence	4.92876733137519e-06
	scope	2.47952243399409e-06
	subject matter	2.2443270059310085e-06
	Idaho	1.8891722776841345e-06
	district court conclusion	1.483546863238696e-06
	reference	5.210472235304009e-07
	present case	3.0719700432474643e-07
	present invention	2.9493424027528643e-07
	question	7.653304035904497e-08
	review court	2.0199054532926613e-08
	use	7.15249649129067e-09
	District	0.0
	Court	0.0
	Appeals	0.0
	Fed	0.0
